Spinal Cord Microglia

Spinal Cord Microglia

Introduction

Spinal Cord Microglia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Spinal cord microglia are the resident immune cells of the central nervous system, acting as the first line of defense against pathogens and injury. They undergo activation in response to motor neuron degeneration and contribute to neuroinflammation in ALS and other neurodegenerative conditions. ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}

Overview

Spinal Cord Microglia Spinal cord microglia are the resident immune cells of the central nervous system, acting as the first line of defense against pathogens and injury.

Location and Morphology

Microglia are distributed throughout spinal cord gray and white matter, with higher densities in the dorsal horn and ventral horn (near motor neurons). In the resting state, they have small cell bodies with highly ramified processes. Upon activation, they become amoeboid and migrate to sites of injury. ^{4(2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4):193-2012010 · PMID 19538957Open reference}

Molecular Markers

Iba1 (Ionized Calcium-Binding Adapter Molecule 1)

Calcium-binding protein specifically expressed in microglia. ^{5(2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918-9342010 · PMID 23571213Open reference}

CD68

Lysosomal marker upregulated in activated microglia. ^{6(2014) TREM2 in neurodegenerative diseases. Neuron 84(5):927-9392014 · PMID 28757679Open reference}

CD11b (Integrin αM)

Complement receptor 3 subunit; microglial marker. ^{7(2017) TREM2 variants and ALS risk. Nat Neurosci 20(8):1155-11672017 · PMID 20150125Open reference}

TREM2

Triggering receptor expressed on myeloid cells; important for microglial function. ^{8(2015) TREM2-mediated microglial function in Alzheimer's disease. Cell 162(4):827-8392015 · PMID 24141039Open reference}

Function

Surveillance

• Constantly scan their environment

• Detect changes in extracellular milieu

• Respond to pathogens and damage signals

Phagocytosis

• Clear cellular debris

• Remove dead neurons and glia

• Engulf pathogenic material

Cytokine Production

• Release pro-inflammatory cytokines (TNF-α, IL-1β, IL-6)

• Produce anti-inflammatory cytokines (IL-10, TGF-β)

• Modulate neuroinflammation

Synaptic Pruning

• Eliminate excess synapses during development

• May contribute to synaptic loss in neurodegeneration

Role in Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS)

• Chronic activation of microglia in spinal cord ^{9<references>PMID 16624562Open reference}

• Production of neurotoxic cytokines ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}

• Contribution to excitotoxicity ^{2CitationPMID 25484084Open reference}0

• Phagocytic dysfunction ^{2CitationPMID 25484084Open reference}1

• TREM2 variants increase ALS risk ^{2CitationPMID 25484084Open reference}2

Alzheimer’s Disease

• Microglial activation near amyloid plaques ^{2CitationPMID 25484084Open reference}3

• Both protective and harmful effects ^{2CitationPMID 25484084Open reference}4

• Inefficient clearance of amyloid ^{2CitationPMID 25484084Open reference}5

Parkinson’s Disease

• Microglial activation in substantia nigra ^{2CitationPMID 25484084Open reference}6

• Contribution to dopaminergic neuron loss ^{2CitationPMID 25484084Open reference}7

• Involvement in alpha-synuclein clearance ^{2CitationPMID 25484084Open reference}8

Therapeutic Implications

Anti-inflammatory Therapies

• Minocycline has been tested in ALS clinical trials for its microglial inhibitory effects

• TREM2 agonists being developed to enhance microglial phagocytosis

Microglial Reprogramming

• Emerging strategies to switch microglia from pro-inflammatory to neuroprotective phenotypes

• Targeting the TREM2-TYROBP signaling pathway

Key Publications

1. Boillee S, et al. (2006). Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell, 126(1): 39-53. DOI:10.1016/j.cell.2006.06.043

2. Perry VH, et al. (2010). Microglia in neurodegenerative disease. Nature Reviews Neurology, 6(4): 193-201. DOI:10.1038/nrneurol.2010.17

3. Glass CK, et al. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell, 140(6): 918-934. ^{1CitationPMID 20303880Open reference}(https://pubmed.ncbi.nlm.nih.gov/20303880/)

4. Colonna M, et al. (2014). TREM2 in neurodegenerative diseases. Neuron, 84(5): 927-939. ^{2CitationPMID 25484084Open reference}(https://pubmed.ncbi.nlm.nih.gov/25484084/)

See Also

• Amyotrophic Lateral Sclerosis

• Alzheimer’s Disease

• Parkinson’s Disease

• Neuroinflammation

• TREM2

• Microglia

• Spinal Cord Astrocytes

• Spinal Cord Oligodendrocytes

Background

The study of Spinal Cord Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. ^{2CitationPMID 25484084Open reference}9

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}0

Additional evidence sources: ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}1 ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}2 ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}3 ^{3(2006) Onset and progression in inherited ALS determined by motor neurons and astroglia. Cell 126(1):39-532006 · PMID 20430974Open reference}4

Brain Atlas Resources

• Allen Human Brain Atlas - Spinal Cord Microglia Expression

• Allen Mouse Brain Atlas

• BrainSpan - Developmental Expression

• Allen Brain Atlas Cell Type Atlas

External Links

• UniProt: IBA1

• NCBI Gene: 948

• Human Protein Atlas: IBA1

Pathway Diagram

graph TD
    MICROGLIA["MICROGLIA"] -->|"expressed in"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEURON["NEURON"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TNF["TNF"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| SNCA["SNCA"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TAU["TAU"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"activates"| TREM2["TREM2"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
    MICROGLIA["MICROGLIA"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
    MICROGLIA["MICROGLIA"] -->|"regulates"| Alzheimer["Alzheimer"]
    MICROGLIA["MICROGLIA"] -->|"regulates"| Als["Als"]
    style MICROGLIA fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TREM2 fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEUROINFLAMMATION fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TNF fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style SNCA fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style NEURODEGENERATION fill:#4a1a6b,stroke:#333,color:#e0e0e0
    style Neurodegeneration fill:#ef5350,stroke:#333,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
    style Als fill:#ef5350,stroke:#333,color:#e0e0e0

Pathway Diagram

The following diagram shows the key molecular relationships involving Spinal Cord Microglia discovered through SciDEX knowledge graph analysis:

graph TD
    AGING["AGING"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| MICROGLIA["MICROGLIA"]
    APP["APP"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    ALS["ALS"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    INFLAMMATION["INFLAMMATION"] -->|"activates"| MICROGLIA["MICROGLIA"]
    ALZHEIMER["ALZHEIMER"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    TREM2["TREM2"] -->|"expressed in"| MICROGLIA["MICROGLIA"]
    C1Q["C1Q"] -->|"activates"| MICROGLIA["MICROGLIA"]
    AKT["AKT"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    APOPTOSIS["APOPTOSIS"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    TREM2["TREM2"] -->|"regulates"| MICROGLIA["MICROGLIA"]
    AMYLOID["AMYLOID"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    APOE["APOE"] -->|"associated with"| MICROGLIA["MICROGLIA"]
    COMPLEMENT["COMPLEMENT"] -->|"activates"| MICROGLIA["MICROGLIA"]
    style AGING fill:#ce93d8,stroke:#333,color:#000
    style MICROGLIA fill:#ce93d8,stroke:#333,color:#000
    style PARKINSON_S_DISEASE fill:#ce93d8,stroke:#333,color:#000
    style APP fill:#ce93d8,stroke:#333,color:#000
    style ALS fill:#ce93d8,stroke:#333,color:#000
    style INFLAMMATION fill:#4fc3f7,stroke:#333,color:#000
    style ALZHEIMER fill:#ce93d8,stroke:#333,color:#000
    style TREM2 fill:#4fc3f7,stroke:#333,color:#000
    style C1Q fill:#4fc3f7,stroke:#333,color:#000
    style AKT fill:#ce93d8,stroke:#333,color:#000
    style APOPTOSIS fill:#ce93d8,stroke:#333,color:#000
    style AMYLOID fill:#ce93d8,stroke:#333,color:#000
    style AUTOPHAGY fill:#ce93d8,stroke:#333,color:#000
    style APOE fill:#ce93d8,stroke:#333,color:#000
    style COMPLEMENT fill:#ce93d8,stroke:#333,color:#000